Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer

OBJECTIVE: Gynecologic cancers are associated with a high risk of venous thromboembolism (VTE). The Khorana score is a validated tool to assess risk of VTE in cancer patients. The purpose of this study is to determine if the Khorana score can be used as a risk stratification tool for VTE in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Piver, Rachael N., Wagner, Vincent M., Levine, Monica D., Backes, Floor J., Chambers, Laura J., Cohn, David E., Copeland, Larry J., Cosgrove, Casey M., Nagel, Christa I., O'Malley, David M., Bixel, Kristin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995928/
https://www.ncbi.nlm.nih.gov/pubmed/36910448
http://dx.doi.org/10.1016/j.gore.2023.101156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995928/
https://www.ncbi.nlm.nih.gov/pubmed/36910448
http://dx.doi.org/10.1016/j.gore.2023.101156

Ejemplares similares